Endo International | ENDP - Capital Social e Reservas



Capital Social e Reservas Alterar Data
AbbVie USD -3.27B 628M 2025-12
Amarin USD 458.89M 6.03M 2025-09
ANI Pharmaceuticals USD 540.72M 34.91M 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Coherus Biosciences USD 61.01M 26.76M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Heron Therapeutics USD 14.88M 42.14M 2025-09
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Ligand Pharmaceuticals USD 1.02B 67.04M 2025-12
Merck USD 51.85B 2.79B 2025-09
Novartis USD 44.75B 2.7B 2025-09
Pacira USD 693.11M 34.1M 2025-12
Perrigo USD 2.94B 1.51B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Phibro Animal Health USD 332.36M 20.68M 2025-12
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12
Takeda JPY 7.64T 513.39B 2025-12
Teva Pharmaceutical Industries USD 7.91B 664M 2025-12
Xeris Pharmaceuticals USD -861K 18.44M 2025-09
Zoetis USD 3.33B 2.07B 2025-12